Health Care Utilization Among Surgically Treated Medicare Beneficiaries with Lung Cancer
Overview
Pulmonary Medicine
Authors
Affiliations
Background: Markers of increased health care utilization are surrogates for adverse events, and one such metric--prolonged length of stay greater than 14 days (PLOS)--was recently endorsed as a provider-level performance measure.
Methods: This is a cohort study (1992 through 2002) aimed to describe increased health care utilization among 21,067 operated lung cancer patients using the Surveillance, Epidemiology, and End-Results-Medicare database. Increased utilization was defined by PLOS, discharge to an institutional care facility (ICF), or readmission within 30 days.
Results: Twelve percent of patients had a PLOS, 13% were discharged to an ICF, and 15% were readmitted. In multivariate analyses, factors associated with a higher odds ratio of PLOS, discharge to ICF, or readmission included age older than 80 years, increasing comorbidity index, not being married, and pneumonectomy (all p < 0.05). Relative to patients living in the West, those in the Midwest or South had a higher odds ratio of PLOS and readmission but a lower odds ratio of discharge to an ICF (all p < 0.05). Adjusted rates of PLOS decreased significantly with time, whereas adjusted ICF and readmission rates increased (all p < 0.01). Patients who required increased utilization had higher adjusted 2.5-year mortality rates compared with those who did not (PLOS, 42% versus 20%; ICF, 32% versus 20%; readmission, 33% versus 19%; all p < 0.001).
Conclusions: Baseline health status and nonclinical factors were associated with increased utilization, nonuniform trends in utilization were observed with time, and increased utilization was associated with worse long-term outcomes. These findings have implications for quality-improvement initiatives that measure increased health care utilization as a surrogate for provider performance.
National outcomes of expedited discharge following esophagectomy for malignancy.
Ebrahimian S, Chervu N, Hadaya J, Cho N, Kronen E, Sakowitz S PLoS One. 2024; 19(2):e0297470.
PMID: 38394104 PMC: 10889881. DOI: 10.1371/journal.pone.0297470.
Assessment of short readmissions following elective pulmonary lobectomy.
Heiden B, Keller M, Meyers B, Puri V, Olsen M, Kozower B Am J Surg. 2022; 225(1):220-225.
PMID: 35970614 PMC: 9900449. DOI: 10.1016/j.amjsurg.2022.07.031.
The Effect of Major and Minor Complications After Lung Surgery on Length of Stay and Readmission.
Finley C, Begum H, Pearce K, Agzarian J, Hanna W, Shargall Y J Patient Exp. 2022; 9:23743735221077524.
PMID: 35128041 PMC: 8811790. DOI: 10.1177/23743735221077524.
Van Haren R, Correa A, Sepesi B, Rice D, Hofstetter W, Roth J J Thorac Dis. 2020; 12(3):184-190.
PMID: 32274083 PMC: 7139035. DOI: 10.21037/jtd.2020.02.08.
Fernandez F, Kosinski A, Burfeind W, Park B, DeCamp M, Seder C Ann Thorac Surg. 2016; 102(2):370-7.
PMID: 27209606 PMC: 5016798. DOI: 10.1016/j.athoracsur.2016.02.098.